Active Fine Chemicals Limited (DSE: ACTIVEFINE)
Health Care · Pharmaceuticals · BD
Tk6.70
-1.47% today · -23.0% 1Y
Active Fine Chemicals Limited (DSE: ACTIVEFINE) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $13.14M.
Over the last twelve months the share price has lost 23.0%, trading between 4.70 and 9.60.
Tweenvest scores Active Fine Chemicals Limited across four factors: quality 50/100, value 59/100, growth 1/100. Its strongest factor is value.
ACTIVEFINE price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $13.14M
- Revenue (TTM)
- $12.64M
- P/E
- —
- EPS
- -0.02
- Dividend yield
- —
- Beta (5Y)
- -0.02
- 52-week high
- Tk9.60
- 52-week low
- Tk4.70
- Avg volume (3M)
- —
- Shares outstanding
- 239.94M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,237.79 | -0.73% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.44 | +0.15% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $156.08 | +3.60% |
| Roche Holding AGSWX: ROP | $368.80B | CHF373.80 | +0.92% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £124.76 | +3.02% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $28.37 | +1.41% |
Figures last refreshed Aug 18, 2026.